Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy
暂无分享,去创建一个
C. Cannon | D. Morrow | S. Murphy | C. Gibson | G. Wong | P. Dibattiste | D. Robertson | L. Demopoulos | D. James | R. Pai | Nicole Kraimer | Peter M Dibattiste | C. Gibson | Sean P. Murphy
[1] F. Villanueva. Myocardial contrast echocardiography in acute myocardial infarction. , 2002, The American journal of cardiology.
[2] L. Wallentin,et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. , 2002, Journal of the American College of Cardiology.
[3] P. Campbell. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. , 2001, The New England journal of medicine.
[4] E. Braunwald,et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. , 2001, JAMA.
[5] C. Vassanelli,et al. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[6] H. Katus,et al. Admission Troponin T Level Predicts Clinical Outcomes, TIMI Flow, and Myocardial Tissue Perfusion After Primary Percutaneous Intervention for Acute ST-Segment Elevation Myocardial Infarction , 2001, Circulation.
[7] H. Katus,et al. Angiographic correlates of a positive troponin T test in patients with unstable angina , 2001, Critical care medicine.
[8] A. Schmermund,et al. Abnormal Coronary Flow Velocity Reserve After Coronary Intervention Is Associated With Cardiac Marker Elevation , 2001, Circulation.
[9] G. Abreo,et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. , 2000, Journal of the American College of Cardiology.
[10] E. Antman,et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. , 2000, Clinical chemistry.
[11] P. Grande,et al. Coronary angiographic findings and troponin T in patients with unstable angina pectoris. , 2000, The American journal of cardiology.
[12] C. Gibson,et al. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. , 2000, The American journal of cardiology.
[13] E. Topol,et al. Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.
[14] C M Gibson,et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.
[15] C. Heeschen,et al. Angiographic findings in patients with refractory unstable angina according to troponin T status. , 1999, Circulation.
[16] E. Vicaut,et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. , 1999, American heart journal.
[17] K. Lee,et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. , 1998, Circulation.
[18] Y. Matsuzawa,et al. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. , 1998, The Journal of clinical investigation.
[19] F. Harrell,et al. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .
[20] S. Iliceto,et al. Myocardial contrast echocardiography in acute myocardial infarction. Pathophysiological background and clinical applications. , 1996, European heart journal.
[21] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[22] M. Hori,et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.
[23] R. Kloner,et al. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.
[24] S. Murphy,et al. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy. , 2002, American heart journal.
[25] Tx Station. Stata Statistical Software: Release 7. , 2001 .
[26] R. Gilbert. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. , 2001, The New England journal of medicine.
[27] Eorge,et al. CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES , 2000 .
[28] F. Harrell,et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. , 1996, The New England journal of medicine.
[29] J. H. Kiyak,et al. Pathogenesis and morphogenesis of microcirculatory disorders in myocardial infarction. Clinical and ultrastructural examination. , 1996, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[30] Zerbino Dd,et al. Pathogenesis and morphogenesis of microcirculatory disorders in myocardial infarction. Clinical and ultrastructural examination. , 1996 .
[31] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.